Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 21114902)

1.

Determination of donor-derived killer immunoglobulin-like receptor (KIR) by sequential genotyping in hematopoietic stem cell-transplanted patients.

Yoshizawa S, Kitahara T, Zhang Y, Akahane D, Gotoh M, Ohyashiki K, Ohyashiki M, Ohyashiki JH.

Hematology. 2010 Dec;15(6):397-405. doi: 10.1179/102453310X12719010991704.

PMID:
21114902
2.

Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.

Gagne K, Busson M, Bignon JD, Balère-Appert ML, Loiseau P, Dormoy A, Dubois V, Perrier P, Jollet I, Bois M, Masson D, Moine A, Absi L, Blaise D, Charron D, Raffoux C; ARS2000 FRM and FGM group.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1366-75. doi: 10.1016/j.bbmt.2009.06.015.

3.

[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].

Dou LP, DA WM, Zhao DD, Wang C, Lu XC, Kang HY, Yan P, Wang FF, Zhu HY, Li HH, Gao CJ, Yu L.

Zhonghua Yi Xue Za Zhi. 2007 Nov 27;87(44):3111-4. Chinese.

PMID:
18269867
4.

Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotype.

Sobecks RM, Askar M, Thomas D, Rybicki L, Kalaycio M, Dean R, Avery R, Mossad S, Copelan E, Bolwell BJ.

Exp Clin Transplant. 2011 Feb;9(1):7-13.

PMID:
21605017
5.

Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.

Symons HJ, Leffell MS, Rossiter ND, Zahurak M, Jones RJ, Fuchs EJ.

Biol Blood Marrow Transplant. 2010 Apr;16(4):533-42. doi: 10.1016/j.bbmt.2009.11.022. Epub 2009 Dec 2.

6.

Killer-cell immunoglobulin-like receptor ligand compatibility in the outcome of Finnish unrelated donor hematopoietic stem cell transplantation.

Sivula J, Volin L, Porkka K, Vettenranta K, Itälä M, Partanen J, Turpeinen H.

Transpl Immunol. 2007 Jul;18(1):62-6. Epub 2007 Apr 19.

PMID:
17584604
7.

[Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].

Bao XJ, He J, Chen ZX, Wu DP, Yao L, Yuan XN, Cen JN, Qiu QC, Di WY, Zhang H, Zhang J, Zhou XH, Xu HX.

Zhonghua Xue Ye Xue Za Zhi. 2007 Aug;28(8):510-3. Chinese.

PMID:
18078124
8.
9.

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.

Pende D, Marcenaro S, Falco M, Martini S, Bernardo ME, Montagna D, Romeo E, Cognet C, Martinetti M, Maccario R, Mingari MC, Vivier E, Moretta L, Locatelli F, Moretta A.

Blood. 2009 Mar 26;113(13):3119-29. doi: 10.1182/blood-2008-06-164103. Epub 2008 Oct 22.

11.

Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.

Giebel S, Locatelli F, Lamparelli T, Velardi A, Davies S, Frumento G, Maccario R, Bonetti F, Wojnar J, Martinetti M, Frassoni F, Giorgiani G, Bacigalupo A, Holowiecki J.

Blood. 2003 Aug 1;102(3):814-9. Epub 2003 Apr 10.

12.

Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation.

Yabe T, Matsuo K, Hirayasu K, Kashiwase K, Kawamura-Ishii S, Tanaka H, Ogawa A, Takanashi M, Satake M, Nakajima K, Tokunaga K, Inoko H, Saji H, Ogawa S, Juji T, Sasazuki T, Kodera Y, Morishima Y; Japan Marrow Donor Program.

Biol Blood Marrow Transplant. 2008 Jan;14(1):75-87.

13.
14.

Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome.

Moroso V, van der Meer A, Tilanus HW, Kazemier G, van der Laan LJ, Metselaar HJ, Joosten I, Kwekkeboom J.

Transpl Int. 2011 Sep;24(9):932-42. doi: 10.1111/j.1432-2277.2011.01286.x. Epub 2011 Jun 14.

PMID:
21672051
15.

Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation.

Sobecks RM, Ball EJ, Askar M, Theil KS, Rybicki LA, Thomas D, Brown S, Kalaycio M, Andresen S, Pohlman B, Dean R, Sweetenham J, Macklis R, Bernhard L, Cherni K, Copelan E, Maciejewski JP, Bolwell BJ.

Bone Marrow Transplant. 2008 Apr;41(8):709-14. doi: 10.1038/sj.bmt.1705954. Epub 2008 Jan 14.

PMID:
18195688
16.

[Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation].

Liang ZY, Ren HY, Cen XN, Qiu ZX, Wang LH, Ou JP, Li Y, Wang MJ, Wang WS, Xu WL, Dong YJ, Yin Y, Sun YH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Feb;21(1):155-60. doi: 10.7534/j.issn.1009-2137.2013.01.032. Chinese.

PMID:
23484711
17.

Role of killer immunoglobulin-like receptor-ligand interactions in human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.

Kanga U, Mourya M, Seth T, George J, Sood P, Sharma R, Saxena A, Mehra NK.

Transplant Proc. 2012 May;44(4):919-21. doi: 10.1016/j.transproceed.2012.03.036.

PMID:
22564585
18.

Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation.

Yu J, Venstrom JM, Liu XR, Pring J, Hasan RS, O'Reilly RJ, Hsu KC.

Blood. 2009 Apr 16;113(16):3875-84. doi: 10.1182/blood-2008-09-177055. Epub 2009 Jan 28.

19.
20.

Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?

Willemze R, Ruggeri A, Purtill D, Rodrigues CA, Gluckman E, Rocha V; Eurocord and of the European Group of Blood and Marrow Transplantation.

Best Pract Res Clin Haematol. 2010 Jun;23(2):283-90. doi: 10.1016/j.beha.2010.05.005. Review.

PMID:
20837340
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk